Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

PDF +
Supplementary
Material

Chronic obstructive pulmonary disease

Efficacy of a new once-daily long-acting inhaled β₂-agonist indacaterol versus twice-daily formoterol in COPD

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Dahl R, Chung KF, Buhl R, et al

Efficacy of a new once-daily long-acting inhaled β₂-agonist indacaterol versus twice-daily formoterol in COPD

Thorax 2010;65:473-479.